Exchange Traded Concepts, LLC Repligen Corp Transaction History

Exchange Traded Concepts, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$140.68 - $188.02 $9,566 - $12,785	68 Added 2.32%	2,996 $487,000
Q1 2022 Apr 26, 2022	BUY	$161.19 - $257.96 $99,293 - $158,903	616 Added 26.64%	2,928 $551,000
Q4 2021 Jan 13, 2022	BUY	$247.59 - $304.47 $10,398 - $12,787	42 Added 1.85%	2,312 $612,000
Q3 2021 Oct 18, 2021	SELL	$194.77 - $324.21 $12,854 - $21,397	-66 Reduced 2.83%	2,270 $656,000
Q2 2021 Jul 30, 2021	BUY	$165.87 - $220.95 $24,217 - $32,258	146 Added 6.67%	2,336 $466,000
Q1 2021 Apr 20, 2021	SELL	$180.37 - $226.26 $145,197 - $182,139	-805 Reduced 26.88%	2,190 $426,000
Q4 2020 Jan 19, 2021	BUY	$148.08 - $206.57 $41,758 - $58,252	282 Added 10.39%	2,995 $574,000
Q3 2020 Oct 30, 2020	BUY	$122.51 - $158.27 $28,912 - $37,351	236 Added 9.53%	2,713 $400,000
Q2 2020 Jul 15, 2020	BUY	$94.33 - $140.48 $233,655 - $347,968	2,477 New	2,477 $306,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.